Zomedica Corp. operates as a veterinary health company, which engages in the discovery, development, and commercialization of pharmaceuticals for the companion pet. It offers products for dogs and cats by focusing on the unmet needs of clinical veterinarians.
Similarly Is Zomedica overvalued? Is Zomedica stock overvalued? Zomedica shares soared near the beginning of 2021, but then plummeted over 80% from their highest share price. In retrospect, it seems like shareholders had pie-in-the-sky dreams for Truforma, the company’s point-of-care diagnostic system.
How many shares of ZOM are there? Share Statistics
| Avg Vol (3 month) 3 | 17.3M |
|---|---|
| Shares Outstanding 5 | 979.9M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 965.89M |
| % Held by Insiders 1 | 2.63% |
Additionally, Why is Zom stock down?
The reason behind the decline goes back into the previous week, when Zomedica announced its third-quarter results after the market close on Nov. 12. The veterinary health company reported revenue in the third quarter of only $22,514. It posted a net loss of $6.3 million, or $0.091 per share.
What is Zom target price?
Stock Price Target ZOM
| High | $ 1.20 |
|---|---|
| Median | $ 1.20 |
| Low | $ 1.20 |
| Average | $ 1.20 |
| Current Price | $ 0.31 |
Is Truforma FDA approved? In April 2020, Zomedica announced that they had completed platform verification of TRUFORMA, which confirms the achievement of instrument design specifications, and follows FDA Medical Device design control guidelines to ensure the product was built correctly.
Is Zomedica undervalued? InvestorPlace’s Mark Hake estimates Zomedica (NYSEAMERICAN:ZOM) is worth between $1.11 and $1.61 a share. That makes ZOM stock a buy at current prices.
Will TXMD stock go up? The average THERAPEUTICSMD stock price prediction forecasts a potential upside of 762.07% from the current TXMD share price of $0.29.
Did BlackRock buy Zom stock?
– 13F, 13D, 13G Filings – Fintel.io.
…
BlackRock Inc. reports 29.83% decrease in ownership of ZOM / Zomedica Pharmaceuticals Corp.
| Security | ZOM / Zomedica Pharmaceuticals Corp. |
|---|---|
| Latest Disclosed Value | $ 3,896,000 |
Who owns the most shares of Zom? Top 10 Owners of Zomedica Corp
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 4.14% | 40,612,378 |
| SSgA Funds Management, Inc. | 2.93% | 28,730,202 |
| BlackRock Fund Advisors | 1.19% | 11,691,103 |
| Cambridge Investment Research Adv… | 1.14% | 11,142,660 |
Who bought Zom?
Pinnacle Wealth Management Group, Inc.
Is Acasti Pharma a good stock to buy? Is ACASTI PHARMA Stock a good buy in 2022, according to Wall Street analysts? The consensus among 1 Wall Street analyst covering (NASDAQ: ACST) stock is to Buy ACST stock.
Will Zomedica get delisted?
The NYSE American LLC told Zomedica that it’s no longer in danger of being delisted. The exchange can remove a stock if it closes at less than $1 for more than 30 consecutive days. That’s no longer the case for Zomedica.
Will Zomedica go up tomorrow?
Tomorrow’s movement Prediction of Zomedica Pharmaceuticals Corp ZOM as on 08 Apr 2022 appears strongly Bullish . This stock started moving upwards as soon as it opened.
…
Munafa value: 55 as on 08 Fri Apr 2022.
| Upside target | 0.33 |
|---|---|
| Upside target | 0.31 |
| Downside target | 0.3 |
| Downside target | 0.29 |
When did ZOM go public? On April 18, 2019, the company became a public company via an initial public offering. After pricing at US$36 per share, the share price increased over 72% on the first day of trading. Prior to the IPO, Dropbox invested $5 million in Zoom.
What is Truforma Zomedica? Truforma is a blood testing kit for veterinarians. It’s based on bulk acoustic wave (BAW) sensors from Qorvo (NASDAQ:QRVO). The waves are run through pet blood samples to test for adrenal and thyroid diseases.
How accurate is Truforma?
TRUFORMA™ achieved statistically significant high correlation of R > 0.95 to the Siemens IMMULITE® Canine tT4 assay (P value < 0.0001). Dynamic range is the functional range of a test over which the concentrations of an analyte can be measured with acceptable accuracy and precision.
Is Zom FDA approved? They have made a product that is all their own, as they have protected their proprietary rights with 70 current and pending patents related to their groundbreaking work. This has also been approved by the FDA. It puts them in an enviable position as they prepare to officially launch sales on March 31st, 2021.
Why is Zomedica stock dropping?
The reason behind the decline goes back into the previous week, when Zomedica announced its third-quarter results after the market close on Nov. 12. The veterinary health company reported revenue in the third quarter of only $22,514. It posted a net loss of $6.3 million, or $0.091 per share.
Why is ZOM dropping? CEO Robert Cohen said the move was precipitated by « changes at our current distributor that we believe have impacted its ability to market our products effectively. » Those words likely startled investors, many of whom decided to sell their shares. Zomedica’s stock price dropped sharply on Thursday.
Is ZOM a meme stock?
A couple of meme stocks that stand out as incredibly risky today are Zomedica ( ZOM 1.80% ) and Digital World Acquisition Corp ( DWAC 0.73% ).
